| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6110660 | Pancreatology | 2016 | 6 Pages |
Abstract
Sarcopenia appears to be a predictor of overall survival in male patients undergoing pancreatic resections, but not specifically for patients with pancreatic ductal adenocarcinoma. As prospective data in future studies are identified, sarcopenia may become a useful tool in predicting outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jill K. Onesti, G. Paul Wright, Sarah E. Kenning, Mark T. Tierney, Alan T. Davis, Michael G. Doherty, Mathew H. Chung,